table of content
1 Introduction to Research & Analysis Reports
1.1 Genomic Cancer Testing Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Genomic Cancer Testing Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Genomic Cancer Testing Overall Market Size
2.1 Global Genomic Cancer Testing Market Size: 2022 VS 2032
2.2 Global Genomic Cancer Testing Market Size, Prospects & Forecasts: 2018-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Genomic Cancer Testing Players in Global Market
3.2 Top Global Genomic Cancer Testing Companies Ranked by Revenue
3.3 Global Genomic Cancer Testing Revenue by Companies
3.4 Top 3 and Top 5 Genomic Cancer Testing Companies in Global Market, by Revenue in 2022
3.5 Global Companies Genomic Cancer Testing Product Type
3.6 Tier 1, Tier 2 and Tier 3 Genomic Cancer Testing Players in Global Market
3.6.1 List of Global Tier 1 Genomic Cancer Testing Companies
3.6.2 List of Global Tier 2 and Tier 3 Genomic Cancer Testing Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Genomic Cancer Testing Market Size Markets, 2022 & 2032
4.1.2 Fluorescence In Situ Hybridization
4.1.3 Polymerase Chain Reaction
4.1.4 Microarray Technology
4.1.5 Serum Proteomics
4.1.6 Nucleic Acid Sequencing
4.2 By Type - Global Genomic Cancer Testing Revenue & Forecasts
4.2.1 By Type - Global Genomic Cancer Testing Revenue, 2018-2023
4.2.2 By Type - Global Genomic Cancer Testing Revenue, 2024-2032
4.2.3 By Type - Global Genomic Cancer Testing Revenue Market Share, 2018-2032
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Genomic Cancer Testing Market Size, 2022 & 2032
5.1.2 Hospitals
5.1.3 Speciality Clinics
5.1.4 Research Institutes
5.1.5 Diagnostics Laboratories
5.1.6 Biopharmaceutical Companies
5.2 By Application - Global Genomic Cancer Testing Revenue & Forecasts
5.2.1 By Application - Global Genomic Cancer Testing Revenue, 2018-2023
5.2.2 By Application - Global Genomic Cancer Testing Revenue, 2024-2032
5.2.3 By Application - Global Genomic Cancer Testing Revenue Market Share, 2018-2032
6 Sights by Region
6.1 By Region - Global Genomic Cancer Testing Market Size, 2022 & 2032
6.2 By Region - Global Genomic Cancer Testing Revenue & Forecasts
6.2.1 By Region - Global Genomic Cancer Testing Revenue, 2018-2023
6.2.2 By Region - Global Genomic Cancer Testing Revenue, 2024-2032
6.2.3 By Region - Global Genomic Cancer Testing Revenue Market Share, 2018-2032
6.3 North America
6.3.1 By Country - North America Genomic Cancer Testing Revenue, 2018-2032
6.3.2 US Genomic Cancer Testing Market Size, 2018-2032
6.3.3 Canada Genomic Cancer Testing Market Size, 2018-2032
6.3.4 Mexico Genomic Cancer Testing Market Size, 2018-2032
6.4 Europe
6.4.1 By Country - Europe Genomic Cancer Testing Revenue, 2018-2032
6.4.2 Germany Genomic Cancer Testing Market Size, 2018-2032
6.4.3 France Genomic Cancer Testing Market Size, 2018-2032
6.4.4 U.K. Genomic Cancer Testing Market Size, 2018-2032
6.4.5 Italy Genomic Cancer Testing Market Size, 2018-2032
6.4.6 Russia Genomic Cancer Testing Market Size, 2018-2032
6.4.7 Nordic Countries Genomic Cancer Testing Market Size, 2018-2032
6.4.8 Benelux Genomic Cancer Testing Market Size, 2018-2032
6.5 Asia
6.5.1 By Region - Asia Genomic Cancer Testing Revenue, 2018-2032
6.5.2 China Genomic Cancer Testing Market Size, 2018-2032
6.5.3 Japan Genomic Cancer Testing Market Size, 2018-2032
6.5.4 South Korea Genomic Cancer Testing Market Size, 2018-2032
6.5.5 Southeast Asia Genomic Cancer Testing Market Size, 2018-2032
6.5.6 India Genomic Cancer Testing Market Size, 2018-2032
6.6 South America
6.6.1 By Country - South America Genomic Cancer Testing Revenue, 2018-2032
6.6.2 Brazil Genomic Cancer Testing Market Size, 2018-2032
6.6.3 Argentina Genomic Cancer Testing Market Size, 2018-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Genomic Cancer Testing Revenue, 2018-2032
6.7.2 Turkey Genomic Cancer Testing Market Size, 2018-2032
6.7.3 Israel Genomic Cancer Testing Market Size, 2018-2032
6.7.4 Saudi Arabia Genomic Cancer Testing Market Size, 2018-2032
6.7.5 UAE Genomic Cancer Testing Market Size, 2018-2032
7 Genomic Cancer Testing Companies Profiles
7.1 Devyser
7.1.1 Devyser Company Summary
7.1.2 Devyser Business Overview
7.1.3 Devyser Genomic Cancer Testing Major Product Offerings
7.1.4 Devyser Genomic Cancer Testing Revenue in Global Market (2018-2023)
7.1.5 Devyser Key News & Latest Developments
7.2 Agendia
7.2.1 Agendia Company Summary
7.2.2 Agendia Business Overview
7.2.3 Agendia Genomic Cancer Testing Major Product Offerings
7.2.4 Agendia Genomic Cancer Testing Revenue in Global Market (2018-2023)
7.2.5 Agendia Key News & Latest Developments
7.3 Illumina
7.3.1 Illumina Company Summary
7.3.2 Illumina Business Overview
7.3.3 Illumina Genomic Cancer Testing Major Product Offerings
7.3.4 Illumina Genomic Cancer Testing Revenue in Global Market (2018-2023)
7.3.5 Illumina Key News & Latest Developments
7.4 Personal Genome Diagnostics
7.4.1 Personal Genome Diagnostics Company Summary
7.4.2 Personal Genome Diagnostics Business Overview
7.4.3 Personal Genome Diagnostics Genomic Cancer Testing Major Product Offerings
7.4.4 Personal Genome Diagnostics Genomic Cancer Testing Revenue in Global Market (2018-2023)
7.4.5 Personal Genome Diagnostics Key News & Latest Developments
7.5 Veracyte
7.5.1 Veracyte Company Summary
7.5.2 Veracyte Business Overview
7.5.3 Veracyte Genomic Cancer Testing Major Product Offerings
7.5.4 Veracyte Genomic Cancer Testing Revenue in Global Market (2018-2023)
7.5.5 Veracyte Key News & Latest Developments
7.6 Pacific Biosciences of California
7.6.1 Pacific Biosciences of California Company Summary
7.6.2 Pacific Biosciences of California Business Overview
7.6.3 Pacific Biosciences of California Genomic Cancer Testing Major Product Offerings
7.6.4 Pacific Biosciences of California Genomic Cancer Testing Revenue in Global Market (2018-2023)
7.6.5 Pacific Biosciences of California Key News & Latest Developments
7.7 Qiagen
7.7.1 Qiagen Company Summary
7.7.2 Qiagen Business Overview
7.7.3 Qiagen Genomic Cancer Testing Major Product Offerings
7.7.4 Qiagen Genomic Cancer Testing Revenue in Global Market (2018-2023)
7.7.5 Qiagen Key News & Latest Developments
7.8 Agilent Technologies
7.8.1 Agilent Technologies Company Summary
7.8.2 Agilent Technologies Business Overview
7.8.3 Agilent Technologies Genomic Cancer Testing Major Product Offerings
7.8.4 Agilent Technologies Genomic Cancer Testing Revenue in Global Market (2018-2023)
7.8.5 Agilent Technologies Key News & Latest Developments
7.9 Natera
7.9.1 Natera Company Summary
7.9.2 Natera Business Overview
7.9.3 Natera Genomic Cancer Testing Major Product Offerings
7.9.4 Natera Genomic Cancer Testing Revenue in Global Market (2018-2023)
7.9.5 Natera Key News & Latest Developments
7.10 Bio Rad Laboratories
7.10.1 Bio Rad Laboratories Company Summary
7.10.2 Bio Rad Laboratories Business Overview
7.10.3 Bio Rad Laboratories Genomic Cancer Testing Major Product Offerings
7.10.4 Bio Rad Laboratories Genomic Cancer Testing Revenue in Global Market (2018-2023)
7.10.5 Bio Rad Laboratories Key News & Latest Developments
7.11 Myriad Genetics
7.11.1 Myriad Genetics Company Summary
7.11.2 Myriad Genetics Business Overview
7.11.3 Myriad Genetics Genomic Cancer Testing Major Product Offerings
7.11.4 Myriad Genetics Genomic Cancer Testing Revenue in Global Market (2018-2023)
7.11.5 Myriad Genetics Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
